arrow
S

Signe S. Torekov

University of Copenhagen
H指数:36
被引数:5,632

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial

运动和利拉鲁肽对体重维持期间血管健康和炎症的影响:S-LiTE试验的事先预定的二次分析

2026-06-240
OAAI
Effects of Incretin‐Based Therapies, Diet and Exercise Interventions, and Bariatric Surgery on Fat‐Free Mass in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis

Busk-Cirera, L.; Carlsen, I.O.; Madsen, L.B.; Sandsdal, R.M.; Jensen, E.; Jensen, S.B.K.; Torekov, S.S. 肠促胰素为基础疗法、饮食和运动干预以及减重手术对超重或肥胖成人去脂体重的影响:一项系统评价和Meta分析。Diabetes Obes. Metab. 2026, 28, 7737–7751. [Google Scholar] [CrossRef] [Scilit] [PubMed]

2026-06-210
OA
Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity

饮食引起的体重减轻后,单独或联合运动和GLP-1受体激动剂治疗的身体健康状况: 对肥胖成人的随机对照试验的二次分析

2026-01-240
OAAI
Exercise maintains LEAP2 levels after weight loss in females with obesity

运动在女性肥胖者体重减轻后维持LEAP2水平

2025-11-280
OAAI
HMGCR and Rosuvastatin Regulates GLP-1 Secretion and Expression-A Translational Study

HMGCR和Rosuvastatin对GLP-1分泌和表达的调控——一项转化研究

2025-11-010
OAAI
One Year of Exercise After Weight Loss Increases Postprandial GLP-1 Secretion in Contrast to Usual Activity or GLP-1 Receptor Agonist Treatment

体重减轻后一年的运动增加了餐后GLP-1分泌,而常规活动或GLP-1受体激动剂治疗则相反。

Obesity
IF4.7
2025-09-250
OAAI
Weight Loss Induces Changes in Vitamin D Status in Women With Obesity But Not in Men: A Randomized Clinical Trial

减肥引起肥胖女性维生素d状况的变化,但不引起男性的变化: 一项随机临床试验

2024-11-121
OA
Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel , superiority, open-label, randomised controlled trial
2024-05-014
OA
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial

通过运动,GLP-1受体激动剂或两者联合维持健康的体重减轻,随后一年不治疗: 一项随机安慰剂对照试验的治疗后分析

2024-03-0129
OAAI
Increased meal-induced neurotensin response predicts successful maintenance of weight loss-Data from a randomized controlled trial

进餐诱导的神经降压素反应增加可预测成功维持体重减轻-来自一项随机对照试验的数据

2023-06-015
PRE
Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial
2023-02-2537
OAAI